REED's, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between December 4, 2025, and December 8, 2025. The primary events include the completion of an underwritten public offering, the uplisting of common stock to the NYSE American, and the adoption of amended bylaws.
Key Financial Metrics and Capital Structure
- Capital Raised: Net proceeds from the public offering were approximately $9.0 million after deducting underwriting discounts, commissions, and offering expenses.
- Securities Issued: The Company sold 2,500,000 shares of Common Stock and warrants to purchase 2,500,000 shares. Additionally, underwriters partially exercised an overallotment option for warrants to purchase an additional 375,000 shares.
- Offering Price: Each share of Common Stock and accompanying warrant were sold at a combined public offering price of $4.00.
- Warrant Terms: Warrants have an exercise price of $4.50 per share, are immediately exercisable, and expire on December 8, 2030.
- Use of Proceeds: Funds are intended for growth initiatives, working capital, general corporate purposes, and potential debt repayment.
- Insider Participation: D&D Source of Life Holding Ltd., the controlling stockholder, and its affiliates purchased approximately $5.0 million of securities in the offering.
Note: This filing does not provide specific revenue, profit, cash flow, margin, or total debt figures for the reporting period.
Material Changes
- Exchange Listing: Common stock began trading on the NYSE American on December 5, 2025, replacing its previous listing on the OTCQX Best Market.
- Corporate Governance: The Second Amended and Restated Bylaws became effective on December 5, 2025. Key changes include enhanced procedural mechanics for stockholder nominations, provisions for remote attendance at meetings, and updated indemnification provisions for directors and officers.
Outlook, Risks, and Contingencies
Management intends to utilize the net proceeds to fund growth and working capital. The filing notes that the Underwriting Agreement contains customary representations, warranties, and indemnification obligations. Warrant holders are subject to beneficial ownership limitations (4.99% or 9.99%) which may restrict exercise unless notice is provided to adjust the threshold.
Investor Verification Checklist
- Verify the final number of shares outstanding post-offering and the impact of the 375,000 warrant overallotment exercise.
- Review the full text of the Second Amended and Restated Bylaws (Exhibit 3.1) for specific details on director nomination procedures and remote meeting protocols.
- Confirm the exact amount of debt, if any, that the Company intends to repay with the $9.0 million in net proceeds.
- Monitor the exercise activity of the warrants issued, given the 4.99%/9.99% beneficial ownership limitations.